Racial and Ethnic Disparities in Research and Clinical Trials

Nicole C Syder1, Nada Elbuluk1

  • 1Department of Dermatology, Keck School of Medicine, University of Southern California, 830 South Flower Street, Ste 100, Los Angeles, CA 90017, USA.

Dermatologic Clinics
|March 18, 2023
PubMed

Insights

Clinical trials need diverse participants for generalizable results. Many dermatology studies lack racial/ethnic diversity and reporting, requiring improved recruitment efforts for equitable medical research.

Area of Science:

  • Medical research
  • Clinical trial methodology
  • Dermatology

Background:

  • Clinical trials are crucial for evaluating treatment safety and efficacy.
  • Generalizability of trial results depends on participant diversity reflecting national/global populations.
  • Dermatology studies often lack racial/ethnic diversity and fail to report minority enrollment data.

Purpose of the Study:

  • To review the challenges and importance of diversity in clinical trials.
  • To highlight the deficit in racial/ethnic diversity and data reporting in dermatology studies.
  • To discuss reasons for underrepresentation and suggest improvements.

Main Methods:

  • Literature review of dermatology clinical trials.
  • Analysis of diversity metrics and reporting practices.
  • Discussion of factors influencing minority participation.

Main Results:

  • A significant number of dermatology studies exhibit insufficient racial/ethnic diversity.
  • Data on minority recruitment and enrollment are frequently missing.
  • Multiple factors contribute to these disparities in clinical trial participation.

Conclusions:

  • Improving diversity in clinical trials is essential for equitable healthcare.
  • Current efforts to enhance diversity in dermatology studies are insufficient.
  • Sustained and meaningful changes in recruitment and reporting are necessary.

Related Concept Videos

Stereotypes, Prejudice, and Discrimination02:55

Stereotypes, Prejudice, and Discrimination

Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who...
90.3K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
436
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Bias01:22

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
4.4K